PPAR Ligands for Cancer Chemoprevention.

Abstract

Peroxisome proliferators-activated receptors (PPARs) that are members of the nuclear receptor superfamily have three different isoforms: PPARalpha, PPARdelta, and PPARgamma. PPARs are ligand-activated transcription factors, and they are implicated in tumor progression, differentiation, and apoptosis. Activation of PPAR isoforms lead to both anticarcinogenesis and anti-inflammatory effect. It has so far identified many PPAR ligands including chemical composition and natural occurring. PPAR ligands are reported to activate PPAR signaling and exert cancer prevention and treatment in vitro and/or in vivo studies. Although the effects depend on the isoforms and the types of ligands, biological modulatory activities of PPARs in carcinogenesis and disease progression are attracted for control or combat cancer development. This short review summarizes currently available data on the role of PPAR ligands in carcinogenesis.

• Authors: Yumiko Yasui, Mihye Kim, Takuji Tanaka
• Journal: PPAR research (PPAR Res) Vol. 2008 Pg. 548919 ( 2008) ISSN: 1687-4757 [Print] United States
• PMID: 18483618 (Publication Type: Journal Article)